“If You Have CF, I Will Eat My Shoe”: Lived experiences and needs of individuals with adult-diagnosed cystic fibrosis

References

• Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519–2531. doi:10.1016/S0140-6736(16)00576-6.
   PubMed Web of Science ®Google Scholar
• Edwards DJ, Wicking K, Smyth W, Shields L, Douglas T. Information needs of parents of infants diagnosed with cystic fibrosis: results of a pilot study. J Child Health Care. 2018;22(3):382–392. doi:10.1177/1367493518760734.
   PubMed Web of Science ®Google Scholar
• Desai S, Wong H, Sykes J, Stephenson AL, Singer J, Quon BS. Clinical characteristics and predictors of reduced survival for adult-diagnosed cystic fibrosis analysis of the Canadian CF registry. Ann Am Thorac Soc. 2018;15(10):1177–1185. doi:10.1513/AnnalsATS.201801-037OC.
   PubMed Web of Science ®Google Scholar
• Widerman E. Communicating a diagnosis of cystic fibrosis to an adult: What physicians need to know. Behav Med. 2002;28(2):45–52. doi:10.1080/08964280209596397.
   PubMed Web of Science ®Google Scholar
• Widerman E. Pathways to adult diagnosis of CF: the impact of pre-diagnosis experience on post-diagnosis responses and needs. Patient Educ Couns. 2004;52(1):69–77. doi:10.1016/S0738-3991(02)00267-7.
   PubMed Web of Science ®Google Scholar
• Rubin HJ, Rubin I. Qualitative Interviewing: The Art of Hearing Data. Thousand Oaks, CA: Sage; 2005.
   Google Scholar
• Guba EG, Lincoln YS. Competing paradigms in qualitative research. In: Denzin NK, Lincoln YS, eds. Handbook of Qualitative Research. Thousand Oaks, CA: Sage Publications; 1994:105–117.
   Google Scholar
• Ponterotto JG. Qualitative research in counseling psychology: a primer on research paradigms and philosophy of science. J Counsel Psychol. 2005;52(2):126–136. doi:10.1037/0022-0167.52.2.126.
   Web of Science ®Google Scholar
• Schwandt TA. Three epistemological stances for qualitative inquiry: interpretivism, hermeneutics, and social constructivism. In Denzin NK, Lincoln YS, eds. Handbook of Qualitative Research. 2nd ed. Thousand Oaks, CA: Sage; 2000:189–213.
   Google Scholar
• Power HA, Shivak SM, Oliver A, et al. Informing the development of an Internet-delivered mental health program for children with cystic fibrosis: a qualitative study. Poster presented at: North American Cystic Fibrosis Conference; October 2019. Nashville, TN.
   Google Scholar
• Shivak S, Power HA, Schmitz T, et al. Informing the development of an Internet-delivered mental health program for healthy siblings of children with cystic fibrosis: a qualitative study. Poster presented at: North American Cystic Fibrosis Conference; October 2019. Nashville, TN.
   Google Scholar
• Widerman E. Knowledge, interests and educational needs of adults diagnosed with cystic fibrosis after age 18. J Cyst Fibros. 2003;2(2):97–104. doi:10.1016/S1569-1993(03)00026-2.
   PubMedGoogle Scholar
• Widerman E. The experience of receiving a diagnosis of cystic fibrosis after age 20: implications for social work. Soc Work Health Care. 2004;39(3-4):415–433. doi:10.1300/J010v39n03_12.
   PubMed Web of Science ®Google Scholar
• Widerman E, Millner L, Sexauer W, Fiel S. Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years. Chest. 2000;118(2):427–433. doi:10.1378/chest.118.2.427.
   PubMed Web of Science ®Google Scholar
• Braun V, Clarke V. Successful Qualitative Research: A Practical Guide for Beginners. Thousand Oaks, CA: Sage. 2013.
   Google Scholar
• Terry G, Hayfield N. Essentials of Thematic Analysis. 1st ed. Washington, DC: American Psychological Association; 2021.
   Google Scholar
• Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Social Science & Medicine. 2022;292:114523. doi:10.1016/j.socsimed.2021.114523.
   PubMed Web of Science ®Google Scholar
• Antoniou S, Elston C. Cystic fibrosis. Medicine. 2016;44(5):321–325. doi:10.1016/j.mpmed.2016.02.016.
   Google Scholar
• Ladores S. The unique challenges and lessons imparted by the cystic fibrosis community in the time of COVID-19 pandemic. J Patient Exp. 2020;7(4):442–443. doi:10.1177/2374373520926360.
   PubMedGoogle Scholar
• Poppelaars FAM, van der Wal G, Braspenning JCC, et al. Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study. Public Health. 2003;117(6):396–403. doi:10.1016/S0033-3506(03)00136-7.
   PubMed Web of Science ®Google Scholar
• Benito-Lozano J, Arias-Merino G, Gómez-Martínez M, et al. Diagnostic process in rare diseases: determinants associated with diagnostic delay. Int J Environ Res Public Health. 2022;19(11):6456. doi:10.3390/ijerph19116456.
   PubMed Web of Science ®Google Scholar
• Lopes MT, Koch VH, Sarrubbi-Junior V, Gallo PR, Carneiro-Sampaio M. Difficulties in the diagnosis and treatment of diseases according to the perceptions of patients, relatives and health care providers. Clinics. 2018;73:e68. doi:10.6061/clinics/2018/e68.
   PubMed Web of Science ®Google Scholar
• Pogue RE, Cavalcanti DP, Shanker S, et al. Rare genetic diseases: update on diagnosis, treatment and online resources. Drug Discov Today. 2018;23(1):187–195. doi:10.1016/j.drudis.2017.11.002.
   PubMed Web of Science ®Google Scholar
• Cystic Fibrosis Canada. Access to Trikafta by location. Cystic fibrosis Canada. https://www.cysticfibrosis.ca/our-programs/advocacy/access-to-medicines/access-to-trikafta-by-location. Update unknown. Accessed December 7, 2023.
   Google Scholar
• Cystic Fibrosis Foundation. Cystic Fibrosis Foundation statement on FDA approval of Trikafta, the first triple combination therapy for the most common CF mutation. Cystic Fibrosis Foundation. https://www.cff.org/press-releases/2019-10/cystic-fibrosis-foundation-statement-fda-approval-trikafta-first-triple. Updated October 21, 2019; Accessed December 7, 2023.
   Google Scholar
• Desai S, Lam GY, Sykes J, Stephenson AL, Quon BS. Eligibility of CFTR modulators for the adult-diagnosed cystic fibrosis population. J Cyst Fibros. 2020;19(5):840–841. doi:10.1016/j.jcf.2020.04.018.
   PubMed Web of Science ®Google Scholar
• Government of Canada. Building a national strategy for drugs for rare diseases: what we heard from Canadians. https://www.canada.ca/content/dam/hc-sc/documents/programs/consultation-national-strategy-high-cost-drugs-rare-diseases-online-engagement/what-we-heard/what-we-heard-national-strategy-high-cost-drugs-eng.pdf. Health. Canada report. Published July 2021. Accessed October 29, 2023.
   Google Scholar
• Government of Canada. Government of Canada improves access to affordable and effective drugs for rare diseases. Health Canada. https://www.canada.ca/en/health-canada/news/2023/03/government-of-canada-improves-access-to-affordable-and-effective-drugs-for-rare-diseases.html. Updated March 22, 2023. Accessed October 29, 2023.
   Google Scholar
• Ali AM, Cobran EK, Young HN. Barriers associated with access to prescription medications in patients diagnosed with type 2 diabetes mellitus treated at federally qualified health centers. Pharmacy (Basel). 2022;10(4):79. doi:10.3390/pharmacy10040079.
   PubMedGoogle Scholar
• Castillo-Laborde C, Hirmas-Adauy M, Matute I, et al. Barriers and facilitators in access to diabetes, hypertension, and dyslipidemia medicines: a scoping review. Public Health Rev. 2022;43:1604796. doi:10.3389/phrs.2022.1604796.
   PubMed Web of Science ®Google Scholar
• Davies G, Rowbotham NJ, Smith S, et al. Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trial. J Cyst Fibros. 2020;19(3):499–502. doi:10.1016/j.jcf.2019.10.025.
   PubMed Web of Science ®Google Scholar
• Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros. 2009;8(2):91–96. doi:10.1016/j.jcf.2008.09.007.
   PubMed Web of Science ®Google Scholar
• Higham L, Ahmed S, Ahmed M. Hoping to live a “normal” life whilst living with unpredictable health and fear of death: impact of cystic fibrosis on young adults. J Genet Couns. 2013;22(3):374–383. doi:10.1007/s10897-012-9555-1.
   PubMed Web of Science ®Google Scholar
• Lowton K. Only when I cough? Adults’ disclosure of cystic fibrosis. Qual Health Res. 2004;14(2):167–186. doi:10.1177/1049732303260675.
   PubMed Web of Science ®Google Scholar
• Lowton K, Gabe J. Life on a slippery slope: perceptions of health in adults with cystic fibrosis. Sociol Health Illn. 2003;25(4):289–319. doi:10.1111/1467-9566.00348.
   PubMed Web of Science ®Google Scholar
• David TJ. Newborn screening for cystic fibrosis. J R Soc Med. 2004;97(5):209–210. doi:10.1177/014107680409700501.
   PubMed Web of Science ®Google Scholar
• Simmonds NJ. Is it cystic fibrosis? The challenges of diagnosing cystic fibrosis. Paediatr Respir Rev. 2019;31:6–8. doi:10.1016/j.prrv.2019.02.004.
   PubMed Web of Science ®Google Scholar
• Casier A, Goubert L, Huse D, et al. The role of acceptance in psychological functioning in 111 adolescents with cystic fibrosis: a preliminary study. Psychol Health. 2008;23(5):629–638. doi:10.1080/08870440802040269.
   PubMed Web of Science ®Google Scholar
• Casier A, Goubert L, Theunis M, et al. Acceptance and well-being in adolescents and young adults with cystic fibrosis: a prospective study. J Pediatr Psychol. 2011;36(4):476–487. doi:10.1093/jpepsy/jsq111.
   PubMed Web of Science ®Google Scholar
• Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care. Chest. 2004;125(1 Suppl):1S–39S. doi:10.1378/chest.125.1_suppl.1S.
   PubMed Web of Science ®Google Scholar
• Warnik D. Health human resource planning in Canada: a typology and its application. Health Policy. 2008;86(1):27–41. doi:10.1016/j.healthpol.2007.08.004.
   PubMed Web of Science ®Google Scholar
• Islam N. The dilemma of physician shortage and international recruitment in Canada. Int J Health Policy Manag. 2014;3(1):29–32. doi:10.15171/ijhpm.2014.53.
   PubMedGoogle Scholar
• Hollenberg D, Lytle M, Walji R, Cooley K. Addressing provider shortage in underserviced areas: The role of traditional, complementary and alternative medicine (TCAM) providers in Canadian rural healthcare. Eur J Integr Med. 2013;5(1):15–26. doi:10.1016/j.eujim.2012.08.008.
   Web of Science ®Google Scholar
• Power HA, Shivak SM, Switzer H, Genoe R, Sharpe D, Wright KD. The internet-delivered cystic fibrosis mental health prevention, wellness, and resource (iCF-PWR) program: Acceptability and utility. Presented at: North American Cystic Fibrosis Conference; November 2022; Philadelphia, PA.
   Google Scholar